View Agent
| Agent Info | |
| Agent: | ertumaxomab |
| Synonyms: | Rexomab;Rexomun;Trifunctional antibody (breast cancer), TRION/Fresenius;Trifunctional bispecific (CD3/human epidermal growth factor receptor 2/neu) antibody (breast cancer), TRION/Fresenius |
| Drug Status For Certain Diseases: | Breast cancer(phase II) |
| Classification: | trifunctional antibody |
| Target: | Receptor protein-tyrosine kinase erbB-2 T-cell surface glycoprotein CD3 epsilon chain CD3 |
| KEGG Pathway: | ErbB signaling pathway Bladder cancer HTLV-I infection Prostate cancer Hematopoietic cell lineage non-small-cell lung cancer Chagas disease (American trypanosomiasis) Primary immunodeficiency Pancreatic cancer Central carbon metabolism in cancer Calcium signaling pathway Pathways in cancer Endometrial cancer Adherens junction Measles HIF-1 signaling pathway T cell receptor signaling pathway Focal adhesion MicroRNAs in cancer |
| Wiki Pathway: | Leptin signaling pathway miR-targeted genes in muscle cell - TarBase Integrated Pancreatic Cancer Pathway Extracellular vesicle-mediated signaling in recipient cells DNA Damage Response (only ATM dependent) TCR signaling TCR Signaling Pathway Signaling by ERBB2 Costimulation by the CD28 family Fcgamma receptor (FCGR) dependent phagocytosis Focal Adhesion Signaling Pathways in Glioblastoma Bladder Cancer EGF/EGFR Signaling Pathway Immunoregulatory interactions bettheyen a Lymphoid and a non-Lymphoid cell ErbB Signaling Pathway Semaphorin interactions |